# Dole share price today (Dole plc, DOLE)

> Dole plc's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. DOLE · Consumer Staples · Farm Products · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/dole

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Turning around, from the last 12 quarters
- Price: $13.08 (+2.7% in a year)
- P/E: 20.9× (lower than 96% of the last 1 year)
- Revenue (Jun 2026): $2.5 B (+2.9% on a year ago)
- Profit (Jun 2026): $35.1 M (+95.3% on a year ago)
- Operating margin: 2.7% (−1.2 points on a year ago)
- ROE: 6%, FY25
- ROIC: 4.5%, against a 5.2% cost of capital: −0.7 points

The main question: the share price moved +2.7% in a year while yearly earnings per share moved −59.7%. The difference came from the market paying a higher multiple. ## What is the Dole share price today? Dole plc's share price was $13.08 at the close on 3 November 2026. That is 8.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $13 and $16, and at that close it sat 9% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 29 weeks running. Over the last 1 year the share price moved −7% while the S&P 500 moved +21%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 17 April 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Dole pay? Dole plc paid $0.34 per share over the last four reported quarters. The most recent declaration was $0.09 for Jun 2026. At today's price of $13.08 that is a yield of 2.60%, based on dividends already paid, not a forecast. ## Which stock lists is Dole on? Dole is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Dole profitable? Dole plc earned $35.1 M of net profit in the Jun 2026 quarter, +95.3% on the same quarter a year earlier. Full-year FY25 profit was $82.0 M. Over 4 years profit has grown 48.2% a year on average. That is 1.4% of the quarter's revenue. The same quarter a year earlier earned $18.0 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $82.0 M (−42.8% on the year before). Why profit moved: revenue changed +2.9% on a year earlier and the margin moved −1.2 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +15.0% and revenue +8.5%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Dole make, and is it growing? Dole plc reported $2.5 B of revenue in the Jun 2026 quarter, +2.9% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 4 years it has grown 11.5% a year on average. The last full year, FY25, came in at $9.2 B. The last four reported quarters add to $9.5 B. FY25 revenue was $9.2 B, +8.2% on the year before. Recent pace: the last four quarters grew +8.5% on average, against 11.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +8.3%, against +6.5% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +78.0%, against −37.4% a year (accelerating). ## How much of every $100 of sales does Dole keep? Dole plc's operating margin was 2.7% in the Jun 2026 quarter, 1.2 percentage points lower than the same quarter a year ago. Across 5 years it has been between 1.5% and 2.9%. The latest quarter is within that range. Why the margin moved: operating margin changed −1.2 percentage points on the year while gross margin changed −1.2 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Dole's profit turning into cash? Over the last 3 years, 165% of Dole plc's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $88.7 M of operating cash against $82.0 M of profit. After $121 M of spending on assets, free cash was −$32.8 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Dole's cash go? Dole plc does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $282 M on assets over the last 3 years. Averaged over those years that is 1.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $282 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Dole's P/E ratio, and how does it compare with its own history? Dole plc's P/E is 20.9×, near the low end of its own history: it has been lower only 4% of the time. Its usual P/E (the middle reading) is 31.2×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −59.7% while the price moved +2.7%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Dole business getting better or worse? Dole plc's business is turning around. Profit growth has swung from −78.0% at its low to +78.0%, improving for 3 quarters in a row, with ROCE steady at 6.1%. This is based on 12 quarters of 4 measures. Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it. ## How much does Dole earn on its capital? Dole plc earned a ROE of 6% in FY25. That is up from a low of 1% in FY21. Its return on capital used (ROIC) is 0.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 0.9% net margin and 2.09× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 0.9% net margin × 2.09× asset turnover × 2.93× leverage (assets divided by equity) ≈ 5.5% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 4.5% − 5.2% = −0.7 percentage points. The 5.2% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 4.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 5.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Dole have too much debt? Dole plc has total debt of $1.4 B against shareholder equity of $1.5 B as of Jun 2026, so its debt is 0.99× its equity. Year by year, that ratio went from 1.40 in FY21 to 0.83 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Dole shareholding pattern? 5.1% of Dole plc's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Dole from balance-sheet trouble? For Dole plc, the Z-score is 2.85. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.85 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Dole rank in its industry? 52.7 out of 100, rank 5 of 11 in Farm Products, with 81% of the evidence available. Dole plc scores 52.7 out of 100 against the 11 companies it is compared with in Farm Products, ranking 5. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 19.3 + 11.7 + 13.8 + 7.9 = 52.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Dole compared with? Dole ranks 5 of 11 Farm Products companies on the 4-Factor Sector Score, with 52.7 out of 100. 1. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) VFF · breaking out · Most evidence points up · 71% evidence 69.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.3/35 · Revenue 15.5% · Profit 100% · Operating margin change 5.8 points · 83% evidence Capital efficiency 14.0/25 · ROCE 9.8% · Operating margin 17.4% · 76% evidence Valuation 11.2/20 · P/E 10.7× · PEG n/a · 15% evidence Relative strength 17.3/20 · Lead over its industry 7.4% · Lead over S&P 500 -6% · 1 year -3.7% · 100% evidence · 11 of 12 weeks ahead Exact sum: 27.3 + 14 + 11.2 + 17.3 = 69.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Alico, Inc.](https://www.sectoralpha.in/us/stocks/alco) ALCO · quiet · Evidence leans up · 64% evidence 57.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Revenue -61.4% · Profit n/a · Operating margin change 93.2 points · 62% evidence Capital efficiency 18.9/25 · ROCE 71.3% · Operating margin 19.8% · 76% evidence Valuation 8.5/20 · P/E 200.3× · PEG n/a · 15% evidence Relative strength 9.8/20 · Lead over its industry 1.5% · Lead over S&P 500 -10.3% · 1 year 12.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 18.9 + 8.5 + 9.8 = 57.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Archer-Daniels-Midland Company](https://www.sectoralpha.in/us/stocks/adm) ADM · quiet · Evidence leans up · 81% evidence 57.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Revenue -0.8% · Profit 61.1% · Operating margin change 1.8 points · 83% evidence Capital efficiency 12.6/25 · ROCE 5.7% · Operating margin 4% · 76% evidence Valuation 13.5/20 · P/E 20.8× · PEG 0.55 · 65% evidence Relative strength 10.2/20 · Lead over its industry 3.7% · Lead over S&P 500 -7.7% · 1 year 23.9% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.2 + 12.6 + 13.5 + 10.2 = 57.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Adecoagro S.A.](https://www.sectoralpha.in/us/stocks/agro) AGRO · turning · Evidence leans up · 74% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 6.3% · Profit 42.9% · Operating margin change 16 points · 62% evidence Capital efficiency 11.7/25 · ROCE 2.6% · Operating margin 17% · 76% evidence Valuation 11.5/20 · P/E 27.5× · PEG 0.65 · 65% evidence Relative strength 8.6/20 · Lead over its industry -1% · Lead over S&P 500 -12.5% · 1 year 15.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.7 + 11.7 + 11.5 + 8.6 = 53.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. Dole plc this page DOLE · basing · Evidence leans up · 81% evidence 52.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 8.3% · Profit 78.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 11.7/25 · ROCE 6.2% · Operating margin 2.7% · 76% evidence Valuation 13.8/20 · P/E 21.9× · PEG 0.22 · 65% evidence Relative strength 7.9/20 · Lead over its industry -1.9% · Lead over S&P 500 -13.7% · 1 year -0.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.3 + 11.7 + 13.8 + 7.9 = 52.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Bunge Global SA](https://www.sectoralpha.in/us/stocks/bg) BG · basing · Evidence leans down · 81% evidence 49.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.2/35 · Revenue 80.5% · Profit -26.9% · Operating margin change 1.8 points · 83% evidence Capital efficiency 14.3/25 · ROCE 7.2% · Operating margin 4.6% · 76% evidence Valuation 11.8/20 · P/E 20.6× · PEG 0.7 · 65% evidence Relative strength 3.1/20 · Lead over its industry -9% · Lead over S&P 500 -19.7% · 1 year 0% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.2 + 14.3 + 11.8 + 3.1 = 49.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Tyson Foods, Inc.](https://www.sectoralpha.in/us/stocks/tsn) TSN · turning · Evidence leans down · 71% evidence 45.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.0/35 · Revenue 2.9% · Profit -26.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 9.8/25 · ROCE 4.2% · Operating margin 2.7% · 76% evidence Valuation 9.2/20 · P/E 35.9× · PEG n/a · 15% evidence Relative strength 14.0/20 · Lead over its industry 3.8% · Lead over S&P 500 -8.6% · 1 year 8.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12 + 9.8 + 9.2 + 14 = 45 · What this means: Relative strength against the index is -8.6%, and revenue and profit growth are weak. 8. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) CALM · basing · Most evidence points down · 85% evidence 32.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 4.5/35 · Revenue -42.5% · Profit -95.4% · Operating margin change -41.3 points · 95% evidence Capital efficiency 8.5/25 · ROCE 0.6% · Operating margin -15.1% · 76% evidence Valuation 16.5/20 · P/E 6× · PEG 0.2 · 65% evidence Relative strength 3.0/20 · Lead over its industry -9.7% · Lead over S&P 500 -20.5% · 1 year -25.4% · 100% evidence · 1 of 12 weeks ahead Exact sum: 4.5 + 8.5 + 16.5 + 3 = 32.5 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Vital Farms, Inc.](https://www.sectoralpha.in/us/stocks/vitl) VITL · basing · Most evidence points down · 71% evidence 31.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.9/35 · Revenue 16.4% · Profit -101.9% · Operating margin change -37.1 points · 83% evidence Capital efficiency 6.1/25 · ROCE 0.1% · Operating margin -24.2% · 76% evidence Valuation 10.2/20 · P/E 21.4× · PEG n/a · 15% evidence Relative strength 5.6/20 · Lead over its industry -36.7% · Lead over S&P 500 -45.6% · 1 year -71.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 9.9 + 6.1 + 10.2 + 5.6 = 31.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Limoneira Company LMNR · quiet · Most evidence points down · 67% evidence 27.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue -19.4% · Profit n/a · Operating margin change 4.7 points · 71% evidence Capital efficiency 4.5/25 · ROCE -10.5% · Operating margin 3.4% · 76% evidence Valuation 8.8/20 · P/E 72.9× · PEG n/a · 15% evidence Relative strength 0.9/20 · Lead over its industry -17.7% · Lead over S&P 500 -27.5% · 1 year -27.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 12.8 + 4.5 + 8.8 + 0.9 = 27 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) AFRI · leader · Too little evidence to rank firmly · 39% evidence 51.5 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Farm Products](https://www.sectoralpha.in/us/sectors/farm-products), all 11 compared on one page. ## Which companies are close to Dole in size? Dole is the 6th largest of 12 Farm Products companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Bunge Global SA, Cal-Maine Foods, Inc. and Adecoagro S.A. Just below it: Vital Farms, Inc., Village Farms International, Inc. and Forafric Global PLC. ### Farm Products companies close in size

1. [Bunge Global SA](https://www.sectoralpha.in/us/stocks/bg) $18.2 billion
2. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) $3.1 billion
3. [Adecoagro S.A.](https://www.sectoralpha.in/us/stocks/agro) $1.4 billion
4. Dole plc $1.2 billion
5. [Vital Farms, Inc.](https://www.sectoralpha.in/us/stocks/vitl) $430 million
6. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) $349 million
7. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) $334 million

[All 12 Farm Products companies, largest first](https://www.sectoralpha.in/us/sectors/farm-products#all-companies)

### Companies close in size in other industries

1. [Nektar Therapeutics](https://www.sectoralpha.in/us/stocks/nktr) $1.3 billion · Biotechnology
2. [Ascentage Pharma Group International](https://www.sectoralpha.in/us/stocks/aapg) $1.3 billion · Biotechnology
3. Dole plc $1.3 billion
4. [Leggett & Platt, Incorporated](https://www.sectoralpha.in/us/stocks/leg) $1.3 billion · Furnishings, Fixtures & Appliances
5. [ZoomInfo Technologies Inc.](https://www.sectoralpha.in/us/stocks/gtm) $1.3 billion · Software - Application

## What else do people ask about Dole? ### What were Dole's latest quarterly results? Dole plc reported revenue of $2.5 B and net profit of $35.1 M for the Jun 2026 quarter. Revenue rose 2.9% and profit rose 95.3% compared with a year earlier. Earnings per share were $0.27. The operating margin was 2.7%, 1.2 percentage points lower than a year earlier (as of 3 November 2026). ### What is Dole's market cap? Dole plc's market capitalisation is $1.2 B at a stock price of $13.08. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Dole performing? Dole plc's latest readings are below. In its latest quarter, revenue rose 2.9% and profit rose 95.3% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 29 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Dole's stock price go up? This page does not forecast Dole plc's stock price. What it shows instead: the stock price is $13.08. Its P/E of 20.9× is higher than 4% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Is Dole's profit real cash? Yes, over the last 3 years, 165% of Dole plc's reported profit came in as cash from operations. The latest year was lower at 108%, so the trend is worth watching. In FY25, operating cash was $88.7 M against reported profit of $82.0 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 3 November 2026). ### Where is Dole in its business cycle? Dole plc's FY25 operating margin was 2.4%, against a 5-year range of 1.5% to 2.9%: the middle of its own range, neither a peak nor a low. The latest quarter was 2.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Dole story? The main question: the share price moved +2.7% in a year while yearly earnings per share moved −59.7%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Dole a stock worth studying right now? What the numbers show: Dole plc's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.